POSB22 Indirect Treatment Comparisons of Empagliflozin Versus Sacubitril/Valsartan for the Treatment of Patients with Heart Failure with Reduced Ejection Fraction (HFREF)
Abstract
Authors
S Smith H Pilkington N Roskell S Linden L Bellanca